Drug Therapy

Holly L. Thacker, MD
Head, Section of Women’s Health, Women’s Health Center; Director, Women’s Health Track, General Internal Medicine Fellowship, The Cleveland Clinic

Address: Holly L. Thacker, MD, Women’s Health Center, A10, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]

Dr. Thacker has indicated that she serves on the speakers’ bureaus of the Pfizer, Wyeth-Ayerst, Eli Lilly, and Merck corporations.

This paper discusses therapies that are not approved by the US Food and Drug Administration for the use under discussion.

Medical Grand Rounds articles are based on edited transcripts from Division of Medicine Grand Rounds presentations at The Cleveland Clinic. They are approved by the author but are not peer-reviewed.

Holly L. Thacker, MD
Head, Section of Women’s Health, Women’s Health Center; Director, Women’s Health Track, General Internal Medicine Fellowship, The Cleveland Clinic

Address: Holly L. Thacker, MD, Women’s Health Center, A10, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]

Dr. Thacker has indicated that she serves on the speakers’ bureaus of the Pfizer, Wyeth-Ayerst, Eli Lilly, and Merck corporations.

This paper discusses therapies that are not approved by the US Food and Drug Administration for the use under discussion.

Medical Grand Rounds articles are based on edited transcripts from Division of Medicine Grand Rounds presentations at The Cleveland Clinic. They are approved by the author but are not peer-reviewed.

Holly L. Thacker, MD
Head, Section of Women’s Health, Women’s Health Center; Director, Women’s Health Track, General Internal Medicine Fellowship, The Cleveland Clinic

Address: Holly L. Thacker, MD, Women’s Health Center, A10, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]

Dr. Thacker has indicated that she serves on the speakers’ bureaus of the Pfizer, Wyeth-Ayerst, Eli Lilly, and Merck corporations.

This paper discusses therapies that are not approved by the US Food and Drug Administration for the use under discussion.

Medical Grand Rounds articles are based on edited transcripts from Division of Medicine Grand Rounds presentations at The Cleveland Clinic. They are approved by the author but are not peer-reviewed.

Jason M. Wolf, MD
Department of Gastroenterology, The Cleveland Clinic

Bret A. Lashner, MD
Director, Center for Inflammatory Bowel Disease, Department of Gastroenterology, The Cleveland Clinic

Address: Bret A. Lashner, MD, Department of Gastroenterology, A30, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]

Jason M. Wolf, MD
Department of Gastroenterology, The Cleveland Clinic

Bret A. Lashner, MD
Director, Center for Inflammatory Bowel Disease, Department of Gastroenterology, The Cleveland Clinic

Address: Bret A. Lashner, MD, Department of Gastroenterology, A30, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]

Jason M. Wolf, MD
Department of Gastroenterology, The Cleveland Clinic

Bret A. Lashner, MD
Director, Center for Inflammatory Bowel Disease, Department of Gastroenterology, The Cleveland Clinic

Address: Bret A. Lashner, MD, Department of Gastroenterology, A30, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]

Maurie Markman, MD
Director, The Cleveland Clinic Taussig Cancer Center; Chairman, Department of Hematology/Medical Oncology, The Lee and Jerome Burkons Research Chair in Oncology, The Cleveland Clinic Foundation

Address: Maurie Markman, MD, The Cleveland Clinic Taussig Cancer Center, R30, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, Ohio 44195; e-mail [email protected]  

Maurie Markman, MD
Director, The Cleveland Clinic Taussig Cancer Center; Chairman, Department of Hematology/Medical Oncology, The Lee and Jerome Burkons Research Chair in Oncology, The Cleveland Clinic Foundation

Address: Maurie Markman, MD, The Cleveland Clinic Taussig Cancer Center, R30, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, Ohio 44195; e-mail [email protected]  

Maurie Markman, MD
Director, The Cleveland Clinic Taussig Cancer Center; Chairman, Department of Hematology/Medical Oncology, The Lee and Jerome Burkons Research Chair in Oncology, The Cleveland Clinic Foundation

Address: Maurie Markman, MD, The Cleveland Clinic Taussig Cancer Center, R30, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, Ohio 44195; e-mail [email protected]  

Emanuel Frisch, MD
Farmington Hills, MI

Emanuel Frisch, MD
Farmington Hills, MI

Emanuel Frisch, MD
Farmington Hills, MI

Toni Choueiri, MD
Division of Medicine, The Cleveland Clinic

Steven R. Deitcher, MD
Director, Clinical Thrombosis and Vascular Research, Section of Vascular Medicine, Department of Cardiovascular Medicine, The Cleveland Clinic

Address: Steven R. Deitcher, MD, Section of Vascular Medicine, Department of Cardiovascular Medicine, S60, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland,OH 44195; e-mail [email protected]

Dr. Deitcher has received grant or research support from Aventis, Pharmacia, and Bristol-Myers Squibb Pharma and is a consultant for and on the speakers’ bureau of Aventis.

Toni Choueiri, MD
Division of Medicine, The Cleveland Clinic

Steven R. Deitcher, MD
Director, Clinical Thrombosis and Vascular Research, Section of Vascular Medicine, Department of Cardiovascular Medicine, The Cleveland Clinic

Address: Steven R. Deitcher, MD, Section of Vascular Medicine, Department of Cardiovascular Medicine, S60, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland,OH 44195; e-mail [email protected]

Dr. Deitcher has received grant or research support from Aventis, Pharmacia, and Bristol-Myers Squibb Pharma and is a consultant for and on the speakers’ bureau of Aventis.

Toni Choueiri, MD
Division of Medicine, The Cleveland Clinic

Steven R. Deitcher, MD
Director, Clinical Thrombosis and Vascular Research, Section of Vascular Medicine, Department of Cardiovascular Medicine, The Cleveland Clinic

Address: Steven R. Deitcher, MD, Section of Vascular Medicine, Department of Cardiovascular Medicine, S60, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland,OH 44195; e-mail [email protected]

Dr. Deitcher has received grant or research support from Aventis, Pharmacia, and Bristol-Myers Squibb Pharma and is a consultant for and on the speakers’ bureau of Aventis.

James L. Orford, MBCHB, MPH
Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minn

Peter B. Berger, MD
Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minn

Address: Peter Berger, MD, Division of Cardiovascular Diseases, Mayo Clinic, W16, 200 First Street SW, Rochester, MN 55905; e-mail [email protected].

James L. Orford, MBCHB, MPH
Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minn

Peter B. Berger, MD
Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minn

Address: Peter Berger, MD, Division of Cardiovascular Diseases, Mayo Clinic, W16, 200 First Street SW, Rochester, MN 55905; e-mail [email protected].

James L. Orford, MBCHB, MPH
Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minn

Peter B. Berger, MD
Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minn

Address: Peter Berger, MD, Division of Cardiovascular Diseases, Mayo Clinic, W16, 200 First Street SW, Rochester, MN 55905; e-mail [email protected].